| Literature DB >> 27142067 |
Søren Mose1,2, David Høyrup Christiansen3, Jens Christian Jensen3, Johan Hviid Andersen3.
Abstract
BACKGROUND: Both musculoskeletal pain-intensity in relation to a specific location (e.g. lower back or shoulder) and pain in multiple body regions have been shown to be associated with impaired function and sickness absence, but the impact of pain intensity on the association between widespread pain and sickness absence has not been studied. Additionally it is unknown whether care-seeking in general practice due to musculoskeletal disorders has a positive or negative impact on future absenteeism. The purpose of this study was to examine the influence of pain intensity on the association between number of musculoskeletal pain sites and sickness absence, and to analyze the impact on absenteeism from care-seeking in general practice due to musculoskeletal disorders.Entities:
Keywords: Care-seeking; Cohort study; Musculoskeletal pain; Pain intensity; Sickness absence; Widespread pain
Mesh:
Year: 2016 PMID: 27142067 PMCID: PMC4855327 DOI: 10.1186/s12891-016-1056-1
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Baseline characteristics of 3745 occupational active participants stratified by duration of sickness absence covering the years 2008 to 2012
| Total | Long-term sickness absencea | Sickness absence of shorter durationb | |
|---|---|---|---|
| All participants, | 3745 (100) | 202 (5.4) | 278 (7.8) |
| Number of regions with any pain (pain-intensity cut-off level > 1) | |||
| 0, | 362 (9.7) | 6 (3.0) | 25 (9.0) |
| 1–2, | 1311 (35.0) | 32 (15.8) | 70 (25.2) |
| 3–5, | 1584 (42.3) | 106 (52.5) | 120 (43.2) |
| 6–7, | 488 (13.0) | 58 (28.7) | 63 (22.6) |
| Number of bothersome pain regions (pain-intensity cut-off level > 2) | |||
| 0, | 1124 (30.0) | 21 (10.4) | 53 (19.1) |
| 1–2, | 1419 (37.9) | 46 (22.8) | 100 (36) |
| 3–5, | 1033 (27.6) | 103 (51.0) | 107 (38.5) |
| 6–7, | 169 (4.5) | 32 (15.8) | 18 (6.4) |
| Number of very bothersome pain regions (pain-intensity cut-off level > 3) | |||
| 0, | 1877 (50.1) | 39 (19.3) | 95 (34.2) |
| 1–2, | 1170 (31.2) | 64 (31.7) | 106 (38.1) |
| 3–5, | 630 (16.8) | 85 (42.1) | 68 (24.5) |
| 6–7, | 68 (1.8) | 14 (6.9) | 9 (3.2) |
| GP contact frequency | |||
| No contact, | 2613 (69.8) | 107 (53.0) | 150 (54.0) |
| At least one GP contact, | 1132 (30.2) | 95 (47.0) | 128 (46.0) |
| Covariates | |||
| Sex. Women, | 2091 (55.8) | 149 (73.8) | 179 (64.4) |
| Age (Years), median (25;75 percentile) | 43 (34;51) | 44 (35;52) | 44 (35;51) |
| Educational levelc | |||
| Low, | 1317 (36.7) | 48 (25.5) | 78 (28.1) |
| Medium, | 1657 (46.2) | 100 (53.2) | 145 (52.2) |
| High, | 613 (17.1) | 40 (21.3) | 41 (14.7) |
| Physical work environmentd | |||
| Heavy lifting at work, | 1024 (30.0) | 32 (20.1) | 51 (20.2) |
| Repetitive work, | 1079 (32.1) | 51 (31.7) | 76 (30.3) |
| Psychosocial work environmente | |||
| High job demands, | 1050 (30.7) | 56 (34.4) | 98 (37.7) |
| High workload, | 864 (25.3) | 51 (31.1) | 82 (31.7) |
| Low decision authority, | 761 (22.6) | 52 (32.9) | 58 (22.7) |
| Low degree of stimulating tasks, | 389 (11.6) | 34 (21.5) | 31 (12.2) |
| Low job satisfaction, | 308 (9.2) | 31 (20.1) | 22 (8.6) |
| Low satisfaction with management, | 896 (26.9) | 59 (38.8) | 74 (29.0) |
| Low support form management, | 905 (27.2) | 57 (35.4) | 73 (28.6) |
| Low support from colleagues, | 712 (21.3) | 44 (27.9) | 47 (18.3) |
a.≥ 52 weeks of recorded sickness absence or permanent reduced work capacity during follow-up
b.Between 12 and 52 weeks of recorded sickness absence during follow-up
c.Missing: n = 158. d.Missing: n = 399. e.Missing: n = 547
Uni - and multivariate logistic regression analysis of the number of body regions with bothersome musculoskeletal pain and other covariates in 2008 and sickness absence during the following four years
| Long-term sickness absence (> 52 weeks of recorded sickness absence or permanent reduced work capacity during follow-up.) | ||||||
| Number of body regions with musculoskeletal pain at baseline | Any paina | Bothersome paina | Very bothersome paina | |||
| (Pain-intensity cut-off level > 1 (Range 1–7)) | (Pain-intensity cut-off level > 2 (Range 1–7)) | (Pain-intensity cut-off level > 3 (Range 1–7)) | ||||
| Model 1 OR (95 % CI)c
| ||||||
| No pain | Ref. | Ref. | Ref. | |||
| 1–2 regions | 1.48 (0.62–3.58) | 1.76 (1.04–2.97) | 2.73 (1.82–4.09) | |||
| 3–5 regions | 4.26 (1.85–9.76) | 5.82 (3.61–9.38) | 7.35 (4.97–10.87) | |||
| 6–7 regions | 8.00 (3.41–18.77) | 12.26 (6.88–21.88) | 12.22 (6.27–23.83) | |||
| Model 2 OR (95 % CI)d
| No GP contact ( | At least one GP contact ( | No GP contact ( | At least one GP contact ( | No GP contact ( | At least one GP contact ( |
| No pain | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
| 1–2 regions | 1.32 (0.50–3.52) | 2.13 (0.27–16.88) | 1.53 (0.82–2.84) | 2.36 (0.86–6.48) | 2.57 (1.52–4.34) | 2.57 (1.34–4.92) |
| 3–5 regions | 3.39 (1.35–8.53) | 6.63 (0.90–48.85) | 4.31 (2.42–7.68) | 8.17 (3.23–20.68) | 6.57 (3.91–11.04) | 6.64 (3.58–12.32) |
| 6–7 regions | 4.64 (1.73–12.43) | 15.59 (2.10–116.05) | 9.09 (4.35–19.03) | 17.61 (6.21–49.93) | 14.37 (6.46–31.96) | 8.32 (2.45–28.32) |
| Model 3 OR (95 % CI)f
| ||||||
| No pain | Ref. | Ref. | Ref. | |||
| 1–2 regions | 1.88 (0.56–6.33) | 1.50 (0.80–2.82) | 1.81 (1.10–2.99) | |||
| 3–5 regions | 3.86 (1.19–12.51) | 3.74 (2.07–6.77) | 4.50 (2.75–7.38) | |||
| 6–7 regions | 6.84 (2.05–22.80) | 8.42 (4.12–17.21) | 9.42 (4.17–21.27) | |||
| Sickness absence of shorter duration (≥ 12 weeks and ≤ 52 weeks of recorded sickness absence during follow-up)e | ||||||
| The number of body regions with musculoskeletal pain at baseline | Any paina | Bothersome paina | Very bothersome painb | |||
| (Pain-intensity cut-off level > 1 (Range 1–7)) | (Pain-intensity cut-off level > 2 (Range 1–7)) | (Pain-intensity cut-off level > 3 (Range 1–7)) | ||||
| Model 1 OR (95 % CI)c
| ||||||
| No pain | Ref. | Ref. | Ref. | |||
| 1–2 regions | 0.77 (0.48–1.23) | 1.56 (1.11–2.20) | 1.95 (1.46–2.60) | |||
| 3–5 regions | 1.17 (0.75–1.83) | 2.56 (1.82–3.61) | 2.60 (1.88–3.61) | |||
| 6–7 regions | 2.24 (1.38–3.65) | 2.93 (1.66–5.17) | 3.52 (1.68–7.40) | |||
| Model 2 OR (95 % CI)d
| No GP contact ( | At least one GP contact ( | No GP contact ( | At least one GP contact ( | No GP contact ( | At least one GP contact ( |
| No pain | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
| 1–2 regions | 0.80 (0.43–1.46) | 0.60 (0.28–1.30) | 1.50 (0.97–2.31) | 1.56 (0.88–2.75) | 2.00 (1.38–2.90) | 1.62 (1.02–2.57) |
| 3–5 regions | 1.35 (0.76–2.39) | 0.68 (0.33–1.42) | 2.17 (1.38–3.42) | 2.48 (1.44–4.27) | 1.99 (1.23–3.21) | 2.57 (1.59–4.15) |
| 6–7 regions | 2.00 (1.04–3.84) | 1.66 (0.77–3.57) | 2.72 (1.26–5.88) | 2.64 (1.12–6.23) | 3.26 (1.23–8.61) | 3.73 (1.15–12.17) |
| Model 3 OR (95 % CI)f
| ||||||
| No pain | Ref. | Ref. | Ref. | |||
| 1–2 regions | 0.76 (0.44–1.31) | 1.44 (0.97–2.14) | 1.81 (1.30–2.53) | |||
| 3–5 regions | 0.98 (0.58–1.65) | 2.14 (1.44–3.20) | 2.04 (1.37–3.02) | |||
| 6–7 regions | 1.82 (1.03–3.23) | 2.34 (1.23–4.44) | 3.08 (1.33–7.11) | |||
aTest for trend: p < 0.001, bTest for trend: p < 0.01, cCrude analyses, dStratified analysis, e189 participants with ≥ 52 weeks of sickness absence during the follow-up period are not included in this analyzes, fAdjusted for: GP contact. Sex, age, educational level, physical and psychosocial work environment. gNumber of participants are reduced due to missing values